Диссертация (1141140), страница 35
Текст из файла (страница 35)
Dantzer [et al.] // Neurobiol. Aging. – 2008. – Vol. 29, № 11. –P. 1744–1753.245. Hui, L. Serum proteomic profiling associated with immune system impaired bystress using ProteinChip technology / L. Hui, H. Diandong, Z. Baoxia [et al.] //Neuroimmunomodulation. – 2007. – Vol. 14, № 6. – P. 326-330.216246. Husse, J. Synchronization of the mammalian circadian timing system: Light cancontrol peripheral clocks independently of the SCN clock: Alternate routes ofentrainment optimize the alignment of the body's circadian clock network with externaltime / J. Husse, G. Eichele, H.
Oster // Bioessays. – 2015. – Vol. 37, № 10. – P. 11191128.247. Jacobs G.H. Evolution of colour vision in mammals // Philos. Trans. R. Soc.Lond. B Biol Sci. – 2009. – Vol. 364, № 1531. – P. - 2957-2967.248. Jacobs, G.H. Influence of cone pigment coexpression on spectral sensitivity andcolor vision in the mouse / G.H. Jacobs, G.A. Williams, J.A.
Fenwick [et al.] / VisionRes. – 2004. – Vol. 44, № 14. – P. 1615-1622.249. Jaworek, J. Melatonin influences pancreatic cancerogenesis / J. Jaworek, A. LejaSzpak // Histol. Histopathol. – 2014. – Vol. 29, № 4. – P. 423-431.250. Jaworek, J. Melatonin as modulator of pancreatic enzyme secretion andpancreatoprotector / J. Jaworek, K. Nawrot-Porabka, A.
Leja-Szpak [et al.] // J. Physiol.Pharmacol. – 2007. – Vol. 58, № 6. – P. 65-80.251. Jehan, S. Sleep Disorders in Postmenopausal Women [Electronic resource] / S.Jehan, A. Masters-Isarilov, I. Salifu [et al.] // J. Sleep Disord Ther. – 2015. – Vol. 4, №5.–Modeofaccess:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621258/pdf/nihms724718.pdf (Date ofaccess: 07.07.2015).252.
Jetten, A.M. Retinoid-related orphan receptors (RORs): critical roles indevelopment, immunity, circadian rhythm, and cellular metabolism // Nucl. Recept.Signal. – 2009. – Vol. 7. – P.1-32.253. Jin, X. Targeted disruption of the mouse Mel(1b) melatonin receptor / X. Jin, C.von Gall, R.L. Pieschl [et al.] // Mol. Cell.
Biol. –2003. – Vol. 23, № 3. – P. 1054-1060.254. Jones, B.E. Modulation of cortical activation and behavioral arousal bycholinergic and orexinergic systems // Ann NY Acad. Sci. – 2008. – Vol. 1129. – P. 2634.255. Jurvelin, H. Transcranial bright light treatment via the ear canals in seasonalaffective disorder: a randomized, double-blind dose-response study [Electronic217resource] / H. Jurvelin, T. Takala, J.
Nissilä [et al.] // BMC Psychiatry. – 2014. – Vol.14.–Modeofaccess:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207317/pdf/12888_2014_Article_288.pdf (Date of access: 15.07.2015).256. Juster, R.P. A clinical allostatic load index is associated with burnout symptomsand hypocortisolemic profiles in healthy workers / R.P. Juster, S. Sindi, M.F. Marin [etal.] // Psychoneuroendocrinology. – 2011. – Vol. 36, № 6. – P. 797-805.257.
Iitaka, C . A role for glycogen synthase kinase-3beta in the mammalian circadianclock / C. Iitaka, K. Miyazaki, T. Akaike [et al.] // J. Biol. Chem. – 2005. – Vol. 280, №33. – P.29397-29402.258. Iriti, M. Melatonin in traditional Mediterranean diets / M. Iriti, E.M. Varoni, S.Vitalini // J. Pineal Res. –2010. – Vol.49, № 2. – P. 101-105.259. Irwin, M Partial night sleep deprivation reduces natural killer and cellularimmune responses in humans / M.
Irwin, J. McClintick, C. Costlow [et al.] // FASEB J.– 1996. – Vol. 10, № 5. – P. 643-653.260. Kamdar, B.B. Night-shift work and risk of breast cancer: a systematic review andmeta-analysis / B.B. Kamdar, A.I. Tergas, F.J. Mateen [et al.] // Breast Cancer Res.Treat. – 2013. – Vol. 138, № 1. – P. 291-301.261. Kadoma, Y. Radical-scavenging activity of melatonin, either alone or incombination with vitamin E, ascorbate or 2-mercaptoethanol as co-antioxidants, usingthe induction period method / Y. Kadoma, S.
Fujisawa // In Vivo. – 2011. – Vol. 25, №1. – P. 49-53.262. Kaewsuk, S. Melatonin attenuates methamphetamine-induced reduction oftyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in theneonatal rat brain / S. Kaewsuk, K. Sae-ung, P. Phansuwan-Pujito [et al.] // NeurochemInt. – 2009. – Vol. 55, № 6. – P. 397-405.263. Kalsbeek, A. Circadian disruption and scn control of energy metabolism / A.Kalsbeek, F.A. Scheer, S. Perreau-Lenz [et al.] // FEBS Lett. – 2011.
– Vol. 585, № 10.– Р. 1412-1426.218264. Karabacak, Y. The effect of modafinil on the rat dopamine transporter anddopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze[Electronic resource]/ Y. Karabacak, S. Sase Y.D. Aher [et al.] // Front. Behav.Neurosci.–2015.–Vol.9,№215.–Modeofaccess:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541367/ (Date of access: 09.09.2015).265. Karatsoreos, I.N. Psychobiologicalallostasis:resistance, resilienceandvulnerability / I.N. Karatsoreos, B.S.
McEwen // Trends Cogn. Sci. – 2011. – Vol. 15,№ 12. – P. 576-584.266. Karbownik, M. Potential anticarcinogenic action of melatonin and otherantioxidants mediated by antioxidative mechanisms // Neuro Endocrinol. Lett. – 2002. –Vol. 23, № 1. – P. 39-44.267. Kasper, S.
The efficacy of agomelatine in previously-treated depressed patients /S. Kasper, G. Hajak // Eur Neuropsychopharmacol. – 2013. – Vol. 23 (8). – P.814-821.268. Katz, G. Jet lag and psychotic disorders / G. Katz // Curr. Psychiatry Rep. – 2011.– Vol. 13, № 3.
– P. 187-192.269. Keller, M. A circadian clock in macrophages controls inflammatory immuneresponses / M. Keller, J. Mazuch, U. Abraham [et al.] // Proc. Natl. Acad. Sci. USA. –2009. – Vol. 106, № 50. – P. 21407-21412.270. Kemp, D.M. Identification and functional characterization of melatonin Mel 1areceptors in pancreatic beta cells: potential role in incretin-mediated cell function bysensitization of cAMP signaling / D.M. Kemp, M. Ubeda, J.F.
Habener // Mol. CellEndocrinol. – 2002. – Vol. 191, № 2. – P. 157-166.271. Kim, M.J. Circadian Rhythm Sleep Disorders / M.J. Kim, J.H. Lee, J.F. Duffy //J. Clin. Outcomes Manag. – 2013. – Vol. 20, № 11. – P. 513-528.272. Kitagami, T. Mechanism of systemically injected interferon-alpha impedingmonoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brainbarrier / T. Kitagami, K. Yamada, H. Miura [et al.] / Brain Res. – 2003. – Vol. 978, №1-2. – P.
104–114.219273. Kitazawa,MCircadianrhythms,metabolism,andinsulinsensitivity:transcriptional networks in animal models // Curr. Diab. Rep. – 2013. – Vol. 13, № 2. –P. 223-228.274. Kivimäki, M. Shift work as a risk factor for future type 2 diabetes: evidence,mechanisms, implications, and future research directions /M. Kivimäki, G.D. Batty, C.Hublin // PLoS Med. – 2011. – Vol. 8, № 12. – P. 1-3.275.
Kon, N. Cell-based inhibitor screening identifies multiple protein kinasesimportant for circadian clock oscillations [Electronic resource] / N. Kon, Y. Sugiyama,H. Yoshitane [et al.] // Commun. Integr. Biol. – 2015. – Vol. 8 (4). – Mode of access :http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594307/pdf/kcib-08-04-982405.pdf(Date of access: 17.09.2015).276. Kong, W. Docosahexaenoic acid prevents dendritic cell maturation, inhibitsantigen-specific Th1/Th17 differentiation and suppresses experimental autoimmuneencephalomyelitis / W. Kong, J.H.
Yen, D. Ganea // Brain Behav. Immun. – 2011. –Vol. 25, № 5. – P.872-882.277. Konturek, S.J. Melatonin in gastroprotection against stress-induced acute gastriclesions and in healing of chronic gastric ulcers / S.J. Konturek, P.C.
Konturek, T.Brzozowski //J. Physiol. Pharmacol. – 2006. – Vol. 57, № 5. – P. 51-66.278. Korf, H.W. The circadian system and melatonin: lessons from rats and mice /H.W. Korf, C. Von Gall, J.H. Stehle // J. Chronobiol. Int. – 2003. – Vol. 20, № 4. – P.697-710.279. Korkmaz, A. Melatonin: An Established Antioxidant Worthy of Use in ClinicalTrials /A. Korkmaz, R.J. Reiter, T.
Topal [et al.] // Mol. Med. – 2009. – Vol. 15, №1-2.– P. 43–50.280. Kovacic, P. Cell signaling, receptors, electrical effects and therapy in circadianrhythm / P. Kovacic, R.J. Somanathan // Recept. Signal Transduct Res. – 2013. – Vol.33, № 5. – P. 267-275.281. Koyama, H. Melatonin at pharmacologic doses increases bone mass bysuppressing resorption through down-regulation of the RANKL-mediated osteoclastformation and activation / H. Koyama, O.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
